AGILENT TECHNOLOGIES INC. $19 (New York symbol A; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 343.3 million; Market cap: $6.5 billion; Price-to-sales ratio: 1.3; WSSF Rating: Average) gets 60% of its revenue from selling testing equipment, mainly to makers of cyclical consumer electronics, such as cellphones. The company is now working on ways to broaden its sources of revenue.
For example, Agilent has teamed up with the University of California at Los Angeles School of Public Health and the Los Alamos National Laboratory to develop testing equipment that will identify dangerous viruses, including H1N1 influenza, also known as swine flu.
Agilent’s automated system analyzes a virus’s genetic components “hundreds of times” faster than current methods. This will help public-health officials control future outbreaks.
Agilent is a buy.
Permalink: http://www.tsinetwork.ca/?p=31686
Tags: A, aggressive, Agilent Technologies, portfolio
Related
Free Subscription to
The Successful Investor Network Daily
In today's economy, it's more important than ever to have clear investment advice that is tailored to your own personal goals. This is where Pat McKeough's conservative safe-investing philosophy comes in. Through TSI Network, you get access to reports, monthly newsletters and premium services that go beyond the daily headlines to give you all the advice and information you need to build a portfolio with long-term growth potential. Simply click on the links below to discover which service is right for you.
TSI Premium Services